FDA Expands Marstacimab Indication in Hemophilia A and B - Poll - MDSpire

FDA Expands Marstacimab Indication in Hemophilia A and B

  • By

  • Kathryn Wighton

  • June 8, 2026

Share

Original Source(s)

Related Content